Skip to main content

Series B Biopharma Companies

Explore 92 biopharma startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
92
Total Funding
$1.7B
Avg Funding
$69.7M
Cities
22

Export 92 Series B Biopharma Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Boulder, United States
$100.0M
raised

Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders.

Mar 2026
Series B

Founder Contacts

41,000+ verified contacts

Doylestown, United States
$89.0M
raised

Pinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs.

Mar 2026
Series B

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$123.0M
raised

Flare Therapeutics is a biotech startup that creates precision therapies for cancer and other disorders by targeting transcription factors.

Mar 2023
Series B

Founder Contacts

41,000+ verified contacts

Bothell, United States
$110.0M
raised

Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.

Mar 2025
Series B

Founder Contacts

41,000+ verified contacts

Torino, Italy
$20.4M
raised

Kither Biotech is a pharmaceutical product company that developmens of new drugs to treat chronic inflammatory diseases

Mar 2022
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 92 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Friday Harbor, United States
$1.8M
raised

Pattern Computer discovers valuable insights in complex data to transform business or research.

Feb 2022
Series B

Founder Contacts

41,000+ verified contacts

Niigata, Japan
$3.2M
raised

UniBio is a biotech company that aims to produce useful proteins in plant cells via synthesis and the transient gene expression method.

Feb 2024
Series B

Founder Contacts

41,000+ verified contacts

Budapest, Hungary
$25.0M
raised

Turbine's platform understands the inner mechanisms of cancer enabling the discovery of novel targets & precision medicinal therapies.

Feb 2026
Series B

Founder Contacts

41,000+ verified contacts

Boston, United States
$193.0M
raised

Aera Therapeutics is a biotechnology firm that employs its own protein nanoparticle (PNP) delivery platform.

Feb 2023
Series B

Founder Contacts

41,000+ verified contacts

Carmel, United States
$30.0M
raised

Sudo Biosciences is a biopharma company that designs and develops medicines that target the tyrosine kinase 2 (TYK2) pseudokinase domain.

Feb 2024
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 92 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
South San Francisco, United States
$254.0M
raised

Kardigan develops personalized medicines using AI and data to target and treat the root causes of cardiovascular diseases.

Oct 2025
Series B

Founder Contacts

41,000+ verified contacts

Portland, United States
$95.0M
raised

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

Sep 2025
Series B

Founder Contacts

41,000+ verified contacts

Foster City, United States
$63.0M
raised

AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.

Sep 2025
Series B

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom
$67.5M
raised

NRG Therapeutics is a drug discovery company focussed on therapeutic approaches that will restore mitochondrial function.

Sep 2025
Series B

Founder Contacts

41,000+ verified contacts

Blue Bell, United States
$3.9M
raised

Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics for the treatment of cancer.

Aug 2025
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 92 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Saint-antoine, France
$38.9M
raised

BrainEver is a operator of a medical research agency intended to offer drugs for the treatment of neurodegenerative disorders.

Jul 2025
Series B

Founder Contacts

41,000+ verified contacts

Singapore, Singapore
$45.0M
raised

Nuevocor operates as a preclinical-stage biotech company.

May 2025
Series B

Founder Contacts

41,000+ verified contacts

Oakland, United States
$70.0M
raised

Tempero Bio develops treatments for Substance Use Disorders as a clinical-stage biopharmaceutical company.

Mar 2025
Series B

Founder Contacts

41,000+ verified contacts

Boston, United States
$65.0M
raised

Ampersand Biomedicines is a multi-product platform that develops programmable medicines that target disease sites precisely.

Mar 2025
Series B

Founder Contacts

41,000+ verified contacts

Stockholm, Sweden
$27.3M
raised

Drug candidates with a unique mechanism of action, aiming to reduce inflammation and pain. Vipoglanstat to enter phase II for endometriosis.

Jan 2025
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 92 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Sha Tin, Hong Kong

Great Bay Bio is a high-tech company developing blue ocean biopharmaceuticals with a digital CMC platform.

Dec 2024
Series B

Founder Contacts

41,000+ verified contacts

San Diego, United States
$25.0M
raised

Pleno is a biotechnology company that aims speeding up disease diagnosis and treatment.

Dec 2024
Series B

Founder Contacts

41,000+ verified contacts

Oss, The Netherlands
$89.7M
raised

Citryll is a developer of pharmaceutical drugs used to treat autoimmune and other human diseases.

Dec 2024
Series B

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$84.0M
raised

TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.

Nov 2024
Series B

Founder Contacts

41,000+ verified contacts

Monrovia, United States
$120.0M
raised

Terray Therapeutics is a biotechnology company that transforms small molecule drug discovery.

Oct 2024
Series B

Founder Contacts

41,000+ verified contacts

Showing 26 to 50 of 92 companies

Ready to Connect with Series B Biopharma Startups?

Get verified founder emails, funding details, and company data for 92 series b biopharma companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked